Related Experiment Video
Updated: Aug 15, 2026

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
Research progress on the application of RPA-CRISPR/Cas12a in the rapid visual detection of pathogenic microorganisms
Tuo Ji1,2,3, Xin Fang4, Yuzhi Gao1,2,3
1Lianyungang Clinical College, Bengbu Medical University and The Second People's Hospital of Lianyungang, Lianyungang, China.
Abstract:
In an increasingly complex global public health landscape, the continuous emergence of novel pathogens and the growing problem of antibiotic resistance highlight the urgent need for rapid, efficient, and precise detection technologies for pathogenic microorganisms. The innovative combination of Recombinase Polymerase Amplification (RPA) and CRISPR/Cas12a enables the rapid amplification of target gene fragments under isothermal conditions and the precise recognition and cleavage of specific nucleic acid sequences. The integration of RPA and CRISPR/Cas12a significantly enhances the sensitivity and accuracy of detection simplifies operational procedures, and reduces the dependence on specialized equipment for testing personnel. This combination demonstrates great potential for application in clinical diagnostics and point-of-care testing. This article provides a detailed overview of the principles of RPA-CRISPR/Cas12a and its latest research progress in the field of pathogen detection, aiming to promote the widespread application of RPA-CRISPR/Cas12a technology in clinical medicine and public health and to offer theoretical support for its further optimization.
Insights
Rapid pathogen detection is crucial due to emerging diseases and antibiotic resistance. The combination of Recombinase Polymerase Amplification (RPA) and CRISPR/Cas12a offers a sensitive, accurate, and simple method for identifying microorganisms.
Area of Science:
- Microbiology
- Molecular Biology
- Biotechnology
Background:
- Emerging novel pathogens and antibiotic resistance necessitate advanced detection methods.
- Current technologies often lack the speed, sensitivity, or accessibility required for global public health challenges.
Purpose of the Study:
- To provide a comprehensive overview of the Recombinase Polymerase Amplification (RPA) and CRISPR/Cas12a integrated system.
- To highlight the research progress and potential applications of RPA-CRISPR/Cas12a in pathogen detection.
Main Methods:
- Utilizes Recombinase Polymerase Amplification (RPA) for rapid, isothermal amplification of target gene fragments.
- Employs CRISPR/Cas12a for precise recognition and cleavage of specific nucleic acid sequences.
- Integrates RPA and CRISPR/Cas12a to enhance detection sensitivity and accuracy.
Main Results:
- The RPA-CRISPR/Cas12a combination demonstrates enhanced sensitivity and accuracy in pathogen detection.
- This integrated system simplifies operational procedures and reduces reliance on specialized equipment.
- The technology shows significant potential for clinical diagnostics and point-of-care testing.
Conclusions:
- RPA-CRISPR/Cas12a is a powerful tool for rapid and precise pathogen detection.
- Its integration offers a promising solution for clinical medicine and public health surveillance.
- Further optimization and application of this technology can bolster global health security.
Related Concept Videos
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
CRISPR/Cas9 Genome Editing

